Previous 10 |
ImmunoGen (NASDAQ: IMGN ) -46% after mirvetuximab soravtansine flunks late-stage study. More news on: ImmunoGen, Inc., Mersana Therapeutics, Nutanix, Stocks on the move, Read more ...
- Preliminary data suggests the addition of HS-110 to Nivolumab may restore responsiveness to treatment after tumor progression on prior checkpoint inhibitor therapy - Median overall survival not yet reached with median follow up of 14.4 months in Cohort A - Improved survival obser...
CORAL GABLES, FL / ACCESSWIRE / February 26, 2019 / The healthcare stock market is one of the few markets which exists in a unique space of opportunity because its encompassing industry is built upon the needs of people, rather than on products that could be considered extraneous. Every pe...
FTE Networks (NYSEMKT: FTNW ) +223% on $116M contract . More news on: FTE Networks, Inc., Heat Biologics, Inc., Zynerba Pharmaceuticals, Stocks on the move, Read more ...
Noteworthy events during the week of February 24 - March 2 for healthcare investors. More news on: uniQure N.V., Bausch Health Companies Inc., CytomX Therapeutics, Healthcare stocks news, , Read more ...
Quick Take Anchiano Therapeutics ( ANCN ) intends to raise $35 million in a U.S. IPO, per an amended regulatory filing . The company is developing a single biologic candidate to treat bladder and other cancers. ANCN has had promising trial results, strong existing investor support of th...
Titan Pharmaceuticals (NASDAQ: TTNP ) +77% as it lauds Probuphine relaunch. More news on: Titan Pharmaceuticals, Inc., ToughBuilt Industries, Inc., Geron Corporation, Stocks on the move, , Read more ...
Phase 2 expansion into first line maintenance therapy follows positive interim results reported in 2018 in combination with Bristol-Myers' Opdivo® (Nivolumab) DURHAM, NC / ACCESSWIRE / January 14, 2019 / Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing ...
News, Short Squeeze, Breakout and More Instantly...
DURHAM, N.C., July 18, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) , (“Scorpius” or the “Company”), an integrated contract development and manufacturing organization (CDMO), today announced the successful execution of its first...
DURHAM, N.C., July 17, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced that the Company’s Board of ...
DURHAM, N.C., June 17, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today reported that it received notice ...